| 2006 |
RPS27L is a direct transcriptional target of p53; a consensus p53-binding site in the first intron of RPS27L was identified, and direct p53 binding was demonstrated both in vitro (EMSA) and in vivo (ChIP). Overexpression of RPS27L promoted apoptosis induced by etoposide, while siRNA silencing of RPS27L inhibited it. |
Genome-wide chip profiling, EMSA, ChIP, luciferase reporter assay, siRNA knockdown, apoptosis assay |
Oncogene |
High |
17057733
|
| 2007 |
RPS27L is a nuclear protein that forms nuclear foci upon DNA damage. Depletion of RPS27L causes deficiency in DNA damage checkpoints, converting p53-mediated cell cycle arrest to apoptosis. RPS27L positively regulates p21 protein expression to facilitate cell cycle arrest. |
siRNA knockdown, immunofluorescence/nuclear foci imaging, cell cycle analysis, flow cytometry, western blot for p21 |
Cancer research |
High |
18056458
|
| 2010 |
The N-terminal region of RPS27L (and RPS27) binds to the central acidic domain of MDM2, forming an in vivo triplex with MDM2-p53 and competing with p53 for MDM2 binding. RPS27L (but not RPS27) is a short-lived MDM2 substrate whose degradation requires the RING or acidic domain of MDM2. Ectopic RPS27L inhibits MDM2-mediated p53 ubiquitination and extends p53 half-life; siRNA silencing of RPS27L decreases p53 levels. Upon p53-activating signals, RPS27L (mainly cytoplasmic) shuttles to the nucleoplasm where it colocalizes with MDM2. |
Co-immunoprecipitation, domain mapping, in vivo ubiquitination assay, pulse-chase half-life assay, siRNA knockdown, immunofluorescence/colocalization, luciferase reporter for p53 transcriptional activity |
Oncogene |
High |
21170087
|
| 2014 |
In a mouse knockout model, Rps27l disruption triggers ribosomal stress that stabilizes Mdm2, which then degrades Mdm4, reducing the Mdm2-Mdm4 E3 ligase activity toward p53, leading to p53-dependent apoptotic depletion of hematopoietic stem cells and postnatal death rescued by Trp53 deletion. Under Trp53+/- background, Rps27l disruption drives genomic instability and loss of heterozygosity of Trp53 to promote lymphomagenesis. |
Mouse germline knockout, genetic epistasis (Rps27l-/-;Trp53-/- double mutant rescue), western blot for Mdm2/Mdm4/p53, flow cytometry of hematopoietic stem cells, tumor incidence analysis, karyotyping |
eLife |
High |
25144937
|
| 2018 |
RPS27L silencing induces autophagy by inactivating mTORC1 (but not mTORC2). Mechanistically, RPS27L silencing shortens the protein half-life of β-TrCP (a substrate receptor of SCF ubiquitin ligase responsible for DEPTOR degradation), leading to DEPTOR accumulation that inhibits mTORC1. Simultaneous DEPTOR silencing partially rescues autophagy and mTORC1 inactivation caused by RPS27L loss. |
siRNA knockdown, autophagy assays (LC3-II, autophagic flux), mTORC1/mTORC2 activity assays, pulse-chase half-life assay for β-TrCP, DEPTOR western blot, double knockdown epistasis, Rps27l-/- MEFs |
Cell death & disease |
High |
30425236
|
| 2018 |
Rps27l inactivation confers radiosensitivity via two mechanisms: (1) imbalanced Mdm2/Mdm4 levels leading to activated p53; (2) elevated Mdm2 binding to Nbs1, which inhibits Nbs1-Atm interaction and subsequent Atm activation, reducing the MRN/Atm DNA damage response signal. Heterozygous deletion of Mdm2 restores the MRN/Atm signal. |
Mouse knockout (Rps27l-/-;Trp53+/-), radiation sensitivity assay, Co-immunoprecipitation (Mdm2-Nbs1 binding), western blot for MRN/Atm pathway, genetic rescue by Mdm2 heterozygous deletion |
Cell death & disease |
High |
29396424
|
| 2020 |
RPS27L directly binds to FANCD2 and FANCI (Fanconi anemia proteins). Upon RPS27L knockdown, FANCD2 and FANCI protein levels are reduced due to accelerated degradation via p62-mediated autophagy-lysosome pathway, which impairs ICL repair and reduces FANCD2 foci formation upon mitomycin C treatment. |
Co-immunoprecipitation (RPS27L-FANCD2/FANCI), siRNA knockdown, immunofluorescence (FANCD2 foci), chloroquine/Beclin1 rescue experiments, MMC sensitivity assay |
Cell death & disease |
High |
33051438
|
| 2020 |
Both RPS27L and RPS27 are substrates of neddylation by MDM2 E3 ubiquitin ligase and deneddylation by NEDP1. Blockage of neddylation (with MLN4924) destabilizes RPS27L and RPS27 by shortening their protein half-lives. Neddylation stabilizes RPS27L to confer cancer cell survival. |
In vivo neddylation assay, siRNA knockdown of MDM2/NEDP1, MLN4924 treatment, pulse-chase half-life assay, apoptosis assay upon knockdown/overexpression |
FASEB journal |
High |
32779270
|
| 2023 |
Rps27 and Rps27l have inversely correlated mRNA abundance across mouse cell types. Rps27- and Rps27l-ribosomes associate preferentially with different mRNA transcripts. Loss-of-function alleles are homozygous lethal at different developmental stages, but expressing Rps27 protein from the endogenous Rps27l locus (or vice versa) completely rescues lethality, demonstrating the two proteins are functionally equivalent and their retention is driven by subfunctionalized expression patterns. |
Endogenous protein tagging, ribosome-associated mRNA profiling, mouse knockout and knock-in genetic rescue, developmental lethality staging |
eLife |
High |
37306301
|
| 2025 |
Muscle-specific Rps27l knock-in mice exhibit increased muscle mass, enlarged myofiber size, higher proportion of fast-twitch myofibers, and enhanced muscle regeneration. RPS27L overexpression promotes myoblast proliferation while inhibiting differentiation. The N-terminal intrinsically disordered region of RPS27L facilitates liquid-liquid phase separation (LLPS) and interacts with IGF1 mRNA/protein to regulate myogenesis. SIX4 (a myogenic transcription factor) negatively regulates Rps27l expression. |
Muscle-specific knock-in mouse model, myofiber size/composition analysis, myoblast overexpression/KD, LLPS assay, RNA-binding/IGF1 interaction assay, SIX4 transcription factor binding assay |
Advanced science |
Medium |
40886325
|
| 2020 |
RPS27L is identified as a direct transcriptional target of p53 lacking the 1st transactivation domain (Δ1stTAD-p53), dependent on the 2nd TAD transcriptional activation activity, confirming RPS27L induction requires at least the 2nd TAD of p53. |
ChIP-seq, luciferase reporter assay, p53 mutant transactivation analysis |
Cancer science |
Medium |
31834974
|